Real-time enrollment status for this familial adenomatous polyposis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:12 PM UTC
| NCT Number | NCT05552755 |
| Recruiting Status | Recruiting |
| Condition | Familial Adenomatous Polyposis |
| Phase | PHASE1 |
| Target Enrollment | 67 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Recursion Pharmaceuticals Inc. |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 17, 2026: Clinical trial NCT05552755 is currently recruiting participants. This phase1 study for familial adenomatous polyposis is actively seeking new participants at 17 locations across the United States. The study is sponsored by Recursion Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05552755 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05552755 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.